<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script><script>window.ScullyIOAngularDisabled = true;</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">News</a><a routerlink="/glossary" routerlinkactive="active" class="nav-link" href="/glossary">About GARD</a><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">En Espanõl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 6944 - Lymphomatoid papulosis</h1></div><div><p><b>Other Names: </b>LyP</p><p><b>Categories: </b><span> Blood Diseases</span><span> Rare Cancers</span><span> Skin Diseases</span><!----></p><p><b>This disease is grouped under: </b></p><p><b>Summary: </b><span><strong>Lymphomatoid papulosis</strong>&nbsp;(LyP) is a non-contagious, chronic skin condition characterized by the eruption of recurring, self-healing bumps (lesions) on the skin.[14862] The lesions typically begin small and then become larger, and they may bleed or ulcerate before becoming scaly and crusty.[14862][14863] They  often develop a red-brown color.[14862] Symptoms associated with lesions may include itching and/or pain, which may be debilitating.[14862][14863] The frequency of eruptions varies over time and from person to person. Lesions may be very persistent, or they may go away for long periods of time before coming back.[14862] They may occur anywhere on the body, but they typically develop on the trunk, arms, and legs, and may develop on the hands, face, and genitalia.[14863][14864] They generally go away on their own over a period of weeks to months (usually between 3 and 8 weeks), with or without scarring.[14863]&nbsp;LyP is not contagious.[14862][14863] The cause of LyP is not known, but there is no evidence that it is hereditary.[14862] Stress is often reported to trigger eruptions of lesions.[14862] The duration of the condition varies from person to person and may last months, years or decades.[14863]<br>
<br>
A diagnosis of LyP requires evaluating the symptoms and having a skin biopsy for various types of laboratory tests.&nbsp;While LyP usually is not classified as a cancer (although there has been some debate), it has characteristics of <a href="https://www.cancer.org/cancer/lymphoma.html" target="_blank">lymphoma</a> under the microscope, and people with LyP have a life-long increased risk of developing lymphoma such as <a href="https://www.clfoundation.org/mycosis-fungoides" target="_blank">mycosis fungoides</a>, <a href="https://www.clfoundation.org/primary-cutaneous-anaplastic-large-cell-lymphoma" target="_blank">PC-ALCL</a>, or <a href="https://www.cancer.org/cancer/hodgkin-lymphoma.html" target="_blank">Hodgkin lymphoma</a>.[14862][14863][14864] In 5 to 20 percent of people with LyP, the condition is either preceded by lymphoma, associated with lymphoma, or followed by lymphoma.[14863][14864] When LyP is diagnosed it is important to rule out these cancers, and for this reason, various blood tests or imaging studies may also be recommended.[14863]<br>
<br>
Treatment for LyP may speed up the healing of existing lesions or prevent new lesions from forming, but it does not change the overall course or duration of the condition.[14863] People with only a few lesions or with no major symptoms or cosmetic concerns may opt to forego treatment. If treatment is desired, topical corticosteroids are an option. Options for people with extensive skin lesions or debilitating symptoms may include topical steroids, <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phototherapy" target="_blank">phototherapy</a>, <a href="https://www.dermnetnz.org/topics/oral-retinoids/" target="_blank">oral</a> or <a href="https://www.dermnetnz.org/topics/topical-retinoids/" target="_blank">topical retinoids</a>, <a href="https://medlineplus.gov/druginfo/meds/a682019.html" target="_blank">methotrexate</a>, or other medications (alone or in combination).[14862][14863] <a href="https://medlineplus.gov/druginfo/meds/a682098.html" target="_blank">Tetracycline</a> is typically used if ulcerated lesions become infected.[14865] In most people with LyP-associated lymphomas, treatment of the lymphoma will also clear the LyP.[14862]<br>
<br>
The long-term outlook (prognosis) in more than 90% of people with LyP is positive, as it usually does not affect overall health.[14862] People with LyP who do not develop cancer have a normal life expectancy. While there is a substantial risk to develop lymphoma, the reported mortality rates from associated lymphomas are low.[14863]</span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Cutaneous Lymphoma Foundation</a></span><br><span>PO Box 374</span><br><span>Birmingham MI, 48012</span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=PureSearch&amp;db=pubmed&amp;term=lymphomatoid%20papulosis%5Bti%5D%20AND%20hasabstract%5Btext%5D%20AND%20English%5Blang%5D%20AND%20%222002%2F01%2F12%2016.11%22%5BPDAT%5D%20%3A%20%222007%2F01%2F12%2016.11%22%5BPDAT%5D" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Lymphomatoid papulosis. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.clinicaltrials.gov/ct2/results?cond=%22Lymphomatoid+papulosis%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to Lymphomatoid papulosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span>The <a href="https://www.clfoundation.org/lymphomatoid-papulosis" target="_blank">Cutaneous Lymphoma Foundation</a> has an information page on lymphomatoid papulosis. Click on The Cutaneous Lymphoma Foundation to view the page.</span></li><li><span><a href="http://www.emedicine.com/derm/topic254.htm" target="_blank">Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br>
</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98842" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span><a href="https://meshb.nlm.nih.gov/record/ui?ui=D017731" target="_blank">MeSH®</a> (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.</span></li><li><span><a href="http://www.dermnetnz.org/dermal-infiltrative/lymphomatoid-papulosis.html" target="_blank">DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.</span></li><li><span>The <a href="https://monarchinitiative.org/disease/Orphanet:98842" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><li><span>Visit the following Facebook groups related to Lymphomatoid papulosis:<br>
<a href="https://www.facebook.com/groups/lymphomatoidpapulosis/" target="_blank">Lymphomatoid papulosis</a><br></span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/" target="_blank">NCATS Home</a></div><div class="col"><a href="/sitemap" target="_self">Site Map</a></div><div class="col"><a href="/glossary" target="_self">Browse Glossary A-Z</a></div><div class="col"><a href="/pages/36/privacy-notice" target="_self">Privacy Notice</a></div><div class="col"><a href="/pages/37/disclaimer" target="_self">Disclaimer</a></div><div class="col"><a href="/pages/38/accessibility" target="_self">Accessibility</a></div><div class="col"><a href="/pages/39/foia" target="_self">FOIA </a></div><div class="col"><a href="http://oig.hhs.gov/" target="_blank">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>

<script src="js/custom.js"></script>

</body></html>